Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
---|
06/24/1992 | CN1017154B Tetracyclic indole derivatives |
06/24/1992 | CN1017152B Preparation for cardiotonic tricyclic imidazolones |
06/24/1992 | CN1017150B Preparation of cardrotonic heterocyclic oxazolones |
06/23/1992 | US5124337 Treating atherosclerosis |
06/23/1992 | US5124336 Azabenzimidazole derivatives which are thromboxane receptor antagonists |
06/23/1992 | US5124335 Substituted pyrollo-fused 6 membered heterocycles as angiotensin ii antagonists |
06/23/1992 | US5124326 Antiarrhythmic, hypotensive agents; diuretics |
06/23/1992 | US5124319 Administering for treatment of neuropathological disorders induced by overstimulation of excitatory amino acid receptors |
06/23/1992 | US5124147 Mixture of antagonist to platelet activating factor and antibody |
06/23/1992 | US5124146 Differential delivery of therapeutic agents across the blood brain barrier |
06/23/1992 | CA1304091C 2,6-bis(chloromethyloxy-carbonyloxymethyl)-pyridine and a process for preparing same |
06/23/1992 | CA1303994C2 Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds |
06/22/1992 | WO1992011364A1 Biosynthetic pdgf antagonists |
06/22/1992 | CA2097603A1 Biosynthetic pdgf antagonists |
06/22/1992 | CA2058228A1 Use of heptastigmine in the therapy of cerebral ictus |
06/22/1992 | CA2058148A1 Process for the preparation of enantiomerically pure thienopyran derivative |
06/22/1992 | CA2058142A1 Thiadiazinones |
06/22/1992 | CA2058100A1 Use of 2beta,16beta-diamino-3a,17-dihydroxy androstane derivatives |
06/21/1992 | CA2057647A1 Transdermal delivery of dobutamine |
06/17/1992 | EP0490820A2 Biphenylyl compounds |
06/17/1992 | EP0490818A1 6-cyclohexyl-2'-0-methyl-adenosine hydrate and uses thereof |
06/17/1992 | EP0490769A1 Aminoalkylketone derivatives, process for their preparation and their therapeutical use |
06/17/1992 | EP0490648A1 Pharmaceutical agents |
06/17/1992 | EP0490587A1 Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin II antagonists |
06/17/1992 | EP0490560A1 1,2,3,6-Tetrahydropyridine derivatives |
06/17/1992 | EP0490263A1 Alpha-oxoacetamide derivatives |
06/17/1992 | EP0490259A2 Aminoacid and peptid derivatives with renin inhibiting properties |
06/17/1992 | EP0490219A1 Substituted dibenz-oxo-thiocinones, -12-oxides and -12,12-dioxides; method for their preparation and their use in medicaments |
06/17/1992 | EP0490183A1 Benzoxazinone and benzothiazinone derivatives endowed with cardiovascular activity |
06/17/1992 | EP0489837A1 Inhibition of lymphocyte adherence to vascular endothelium utilizing a novel extracellular matrix receptor-ligand interaction |
06/17/1992 | CN1061971A Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
06/17/1992 | CN1061970A Benzopyran derivatives having anti-hypertensive and vasodilatory activity, their preparation and their therapuetic use |
06/17/1992 | CN1061963A 4-substituted piperidine derivatives for use in therapy |
06/17/1992 | CN1061905A 硬胶囊制剂 Hard capsule preparation |
06/16/1992 | US5122610 Renin inhibitor intermediates |
06/16/1992 | US5122596 Polypeptides useful as blockers of calcium channels |
06/16/1992 | US5122542 Hypotriglyceridemic use of certain bis (3,5-di-alkyl-4-hydroxyphenylthio)methanes |
06/16/1992 | US5122524 Triazinone compounds compositions thereof and metal of use |
06/15/1992 | CA2057534A1 Acid amides |
06/15/1992 | CA2057511A1 Biphenylyl compounds |
06/14/1992 | WO1992010570A1 Leukemia inhibitory factor receptors |
06/14/1992 | WO1992010190A1 Novel csaids |
06/14/1992 | CA2098177A1 Csaids |
06/14/1992 | CA2097291A1 Leukemia inhibitory factor receptors |
06/14/1992 | CA2057357A1 Substituted dibenz-oxa-thiocinones, -12-oxides and -12, 12-dioxides, a process for their preparation and their use in medicaments |
06/14/1992 | CA2056582A1 1,2,3,6-tetrahydropyridine derivatives |
06/13/1992 | CA2057138A1 Aminoalkyl ketone derivatives, process for preparing them and their use in therapy |
06/11/1992 | WO1992009600A1 Benzofuran and benzthiophene derivatives |
06/11/1992 | WO1992009566A1 Novel hydroxamic acid and n-hydroxyurea derivatives and their use |
06/11/1992 | WO1992009561A1 New amide derivatives |
06/11/1992 | WO1992009297A1 Hiv protease inhibitors |
06/11/1992 | WO1992009293A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/11/1992 | WO1992009278A1 Substituted 5-aryl imidazoles |
06/11/1992 | WO1992007832A3 Substituted piperazines as central nervous system agents |
06/11/1992 | DE4039559A1 Funktionalisierte vinylazole, verfahren zu deren herstellung, pharmazeutische praeparate die diese vinylazole enthalten sowie deren verwendung zur herstellung von arzneimitteln Functionalized vinylazoles, processes for their preparation, pharmaceutical compositions containing them and their use for vinylazoles preparation of medicaments |
06/11/1992 | DE4038947A1 Dithiolano- und dithianoglycin-haltige renininhibitorische peptide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Dithiolano- and dithianoglycin-containing peptide renininhibitorische, process for their production and their use in medicinal products |
06/11/1992 | DE4038921A1 Renininhibitorische peptide vom cyclohexylstatin-typ, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln Renininhibitorische peptide from cyclohexylstatin-type, process for their production and their use in medicinal products |
06/11/1992 | CA2097617A1 Inhibition of cell adhesion protein-carbohydrate interactions |
06/10/1992 | EP0489647A2 N,O-sulfated heparosanes; process to produce the same and pharmaceutical compositions containing them |
06/10/1992 | EP0489547A1 A process for the preparation of a 3-alkylated indole, intermediates, and a process for the preparation of a derivative thereof |
06/10/1992 | EP0489404A2 Method of treating shock using a potassium channel activator |
06/10/1992 | EP0489327A1 Chroman derivatives |
06/10/1992 | EP0489300A2 Tetralones with pharmacological activity |
06/10/1992 | EP0489102A1 Pharmaceutical compositions containing aromatic polymers and therapeutic methods using the same |
06/10/1992 | CN1061778A Aminodiol derivatives |
06/10/1992 | CN1061775A Hydroxamic acid and n-hydroxyurea derivatives and their use |
06/10/1992 | CA2098101A1 A vaccine against cholesterol to prevent hypercholesterolemia and atherosclerosis |
06/09/1992 | US5120852 Process for preparing (1r,2r)-2-(3-pyridyl)-tetrahydrothiopyran-2-carbothioamide 1-oxides thereby |
06/09/1992 | US5120848 Imidazole derivatives |
06/09/1992 | US5120782 Substituted pyrrolo-pyridines pharmaceuticals |
06/09/1992 | US5120766 Anticholesterol, antilipemic agent |
06/09/1992 | US5120758 Treating allergic, inflammatory, cardiovascular, pulmonary, arthritic, cutaneous disorders |
06/09/1992 | US5120747 Platelet activating factor antagonists |
06/09/1992 | US5120744 Substituted (quinolin-2-yl-methoxy)phenylthioureas |
06/09/1992 | US5120729 Beta-lactams as antihypercholesterolemics |
06/09/1992 | CA1303045C Selective inhibitors for benzylaminoxidases with respect to other aminoxidases |
06/09/1992 | CA1303042C Piperazinyl-pyridines and piperazinyl-imidazoles and their use as anti-dysrhythmia agents |
06/09/1992 | CA1303038C Diselenobis benzoic acid amides of primary heterocyclic amines, process for producing the same and pharmaceutical compounds comprisingthe same |
06/09/1992 | CA1303025C 17-.beta. A-OH 19-NORSTEROIDS SUBSTITUTED IN 17A, PROCESS FOR THEIR PREPARATION, THEIR USE AS MEDICINES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM |
06/09/1992 | CA1302888C Therapeutic agent for the treatment of disorders associated with cerebral ischemia |
06/08/1992 | WO1992010575A1 Bifunctional inhibitors of thrombin and platelet activation |
06/08/1992 | WO1992010172A1 Solid dosage forms of almokalant and processes for manufacture thereof |
06/08/1992 | CA2097178A1 Solid dosage forms of almokalant and processes for manufacture thereof |
06/08/1992 | CA2096545A1 Bifunctional inhibitors of thrombin and platelet activation |
06/08/1992 | CA2057181A1 Scrotonergic .alpha.-oxoacetamide |
06/08/1992 | CA2057089A1 Substituted pyrazolopyrimidines and imidazopyridazines as angiotensin ii antagonists |
06/08/1992 | CA2056967A1 Use of organic compounds |
06/06/1992 | CA2056922A1 Tetralones with pharmacological activity |
06/06/1992 | CA2056845A1 Chroman derivatives |
06/06/1992 | CA2055376A1 Method of treating shock using a potassium channel activator |
06/04/1992 | CA2056878A1 N,o-sulphated heparosans, process for preparing them and pharmaceutical compositions containing them |
06/03/1992 | EP0488897A1 New guanidine derivatives, process for their preparation and pharmaceutical compositions containing them |
06/03/1992 | EP0488532A1 Indole- and benzimidazole-substituted imidazole and benzimidazole derivatives |
06/03/1992 | EP0488345A1 1,4-Dihydropyridine derivatives and methods of producing the same |
06/03/1992 | EP0488210A1 Process for preparing 1,5-benzothiazepine derivative |
06/03/1992 | EP0488181A1 Hard capsule preparation containing nifedipine |
06/03/1992 | EP0488107A2 Tricyclic benzodiazole analogs and their use in the treatment of cardiovascular disorders |
06/03/1992 | EP0488059A2 Use of a combination of an ace inhibitor with a calcium antagonist in the treatment of proteinuria |
06/03/1992 | EP0487980A1 Aminodiols-derivatives |
06/03/1992 | EP0219539B1 Transdermal nitroglycerin delivery system |